pulmonologyadvisor1d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
FDA approves first ever medication for obstructive sleep apnea — here's what that means
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
thecardiologyadvisor.com3d
CRP Levels May Improve Detection of Hypertension, Insulin Resistance in OSA
For individuals with mmOSA, CRP levels were associated with hypertension risk and insulin resistance among those aged less than 60 years.
Hospital offers program to assist with sleep
Do you experience an inclination for snoring, daytime sleepiness, obesity, high blood pressure, impaired concentration and ...